141 related articles for article (PubMed ID: 15945589)
21. Comparative efficacy and safety of olanzapine and risperidone in the treatment of psychiatric and behavioral symptoms of Alzheimer's disease: Systematic review and meta-analysis.
Zhang Z; Zhang X; Xu L
Medicine (Baltimore); 2024 Jul; 103(27):e35663. PubMed ID: 38968479
[TBL] [Abstract][Full Text] [Related]
22. Experience with the atypical antipsychotics--risperidone and olanzapine in the elderly.
Madhusoodanan S; Suresh P; Brenner R; Pillai R
Ann Clin Psychiatry; 1999 Sep; 11(3):113-8. PubMed ID: 10482120
[TBL] [Abstract][Full Text] [Related]
23. [Efficacy of atypical antipsychotics in patients with Alzheimer's dementia. CATIE-AD-Study (Clinical Antipsychotic Trials of Intervention Effectiveness Alzheimer's Disease)].
Förstl H
Internist (Berl); 2007 Jun; 48(6):642-4. PubMed ID: 17497111
[No Abstract] [Full Text] [Related]
24. Behavioral and psychological symptoms of dementia (BPSD) in elderly demented subjects: is the long lasting use of atypical antipsychotic drugs useful and safe?
Angelini A; Bendini C; Neviani F; Neri M
Arch Gerontol Geriatr; 2007; 44 Suppl 1():35-43. PubMed ID: 17317431
[TBL] [Abstract][Full Text] [Related]
25. Treatment of behavioural and psychiatric symptoms in dementia: implications of recent safety warnings.
Bullock R
Curr Med Res Opin; 2005 Jan; 21(1):1-10. PubMed ID: 15881470
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.
Schneider LS; Tariot PN; Dagerman KS; Davis SM; Hsiao JK; Ismail MS; Lebowitz BD; Lyketsos CG; Ryan JM; Stroup TS; Sultzer DL; Weintraub D; Lieberman JA;
N Engl J Med; 2006 Oct; 355(15):1525-38. PubMed ID: 17035647
[TBL] [Abstract][Full Text] [Related]
27. Second-generation antipsychotic use in children and adolescents: a six-month prospective cohort study in drug-naïve patients.
Arango C; Giráldez M; Merchán-Naranjo J; Baeza I; Castro-Fornieles J; Alda JA; Martínez-Cantarero C; Moreno C; de Andrés P; Cuerda C; de la Serna E; Correll CU; Fraguas D; Parellada M
J Am Acad Child Adolesc Psychiatry; 2014 Nov; 53(11):1179-90,1190.e1-4. PubMed ID: 25440308
[TBL] [Abstract][Full Text] [Related]
28. Is there a real difference in severity of tardive dyskinesia between risperidone and olanzapine?
Suzuki T; Takeuchi H; Watanabe K
J Clin Psychiatry; 2010 Nov; 71(11):1553-4; author reply 1554. PubMed ID: 21114953
[No Abstract] [Full Text] [Related]
29. Effect of early dysphoric response and cannabis use on discontinuation of olanzapine or risperidone in patients with early psychosis.
van Nimwegen-Campailla L; van Beveren N; Laan W; van den Brink W; Linszen D; de Haan L
Pharmacopsychiatry; 2010 Nov; 43(7):281. PubMed ID: 20839158
[No Abstract] [Full Text] [Related]
30. Comparison of olanzapine and risperidone in the treatment of psychosis and associated behavioral disturbances in patients with dementia.
Deberdt WG; Dysken MW; Rappaport SA; Feldman PD; Young CA; Hay DP; Lehman DL; Dossenbach M; Degenhardt EK; Breier A
Am J Geriatr Psychiatry; 2005 Aug; 13(8):722-30. PubMed ID: 16085789
[TBL] [Abstract][Full Text] [Related]
31. Bradycardia at low doses of risperidone.
Tran KT; Golden P; Lark T; Jacob NJ
Am J Psychiatry; 2004 Dec; 161(12):2325-6. PubMed ID: 15569911
[No Abstract] [Full Text] [Related]
32. Comparison of olanzapine to risperidone in substance-abusing individuals with schizophrenia.
Akerele E; Levin FR
Am J Addict; 2007; 16(4):260-8. PubMed ID: 17661193
[TBL] [Abstract][Full Text] [Related]
33. Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics.
Finkel S; Kozma C; Long S; Greenspan A; Mahmoud R; Baser O; Engelhart L
Int Psychogeriatr; 2005 Dec; 17(4):617-29. PubMed ID: 16202186
[TBL] [Abstract][Full Text] [Related]
34. Effectiveness of safety warnings in atypical antipsychotic drugs: an interrupted time-series analysis in Spain.
Sanfélix-Gimeno G; Cervera-Casino P; Peiró S; López-Valcarcel BG; Blázquez A; Barbera T
Drug Saf; 2009; 32(11):1075-87. PubMed ID: 19810779
[TBL] [Abstract][Full Text] [Related]
35. Longitudinal effect of olanzapine on fasting serum lipids: a randomized, prospective, 4-month study.
Kinon BJ; Liu-Seifert H; Ahl J; Ahmed S; Baker RW
Ann N Y Acad Sci; 2004 Dec; 1032():295-6. PubMed ID: 15677433
[TBL] [Abstract][Full Text] [Related]
36. Do atypical antipsychotics cause stroke?
Herrmann N; Lanctôt KL
CNS Drugs; 2005; 19(2):91-103. PubMed ID: 15697324
[TBL] [Abstract][Full Text] [Related]
37. Comment on Nasrallah et al: lower mortality in geriatric patients receiving risperidone and olanzapine versus haloperidol.
Blazer DG
Am J Geriatr Psychiatry; 2004; 12(6):658-9; author reply 659-60. PubMed ID: 15545335
[No Abstract] [Full Text] [Related]
38. Comparison of risperidone with olanzapine in elderly patients with dementia and psychosis.
Ellingrod VL; Schultz SK; Ekstam-Smith K; Kutscher E; Turvey C; Arndt S
Pharmacotherapy; 2002 Jan; 22(1):1-5. PubMed ID: 11794418
[TBL] [Abstract][Full Text] [Related]
39. Obsessive-compulsive symptoms in patients with schizophrenia: a naturalistic cross-sectional study comparing treatment with clozapine, olanzapine, risperidone, and no antipsychotics in 543 patients.
Scheltema Beduin AA; Swets M; Machielsen M; Korver N;
J Clin Psychiatry; 2012 Nov; 73(11):1395-402. PubMed ID: 23218156
[TBL] [Abstract][Full Text] [Related]
40. Meta-analysis of the effectiveness of atypical antipsychotics for the treatment of behavioural problems in persons with dementia.
Yury CA; Fisher JE
Psychother Psychosom; 2007; 76(4):213-8. PubMed ID: 17570959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
